Works matching AU Lee, Jae‐Lyun

Results: 119
    1
    2
    3
    4
    5
    6
    7
    8

    Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.

    Published in:
    Oncologist, 2024, v. 29, n. 2, p. 142, doi. 10.1093/oncolo/oyad231
    By:
    • Choueiri, Toni K;
    • Tomczak, Piotr;
    • Park, Se Hoon;
    • Venugopal, Balaji;
    • Symeonides, Stefan;
    • Hajek, Jaroslav;
    • Ferguson, Thomas;
    • Chang, Yen-Hwa;
    • Lee, Jae Lyun;
    • Haas, Naomi;
    • Sawrycki, Piotr;
    • Sarwar, Naveed;
    • Gross-Goupil, Marine;
    • Thiery-Vuillemin, Antoine;
    • Mahave, Mauricio;
    • Kimura, Go;
    • Perini, Rodolfo F;
    • Saretsky, Todd L;
    • Bhattacharya, Rituparna;
    • Xu, Lei
    Publication type:
    Article
    9

    Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma.

    Published in:
    Oncologist, 2023, v. 28, n. 1, p. 59, doi. 10.1093/oncolo/oyac142
    By:
    • Bergerot, Cristiane;
    • Rha, Sun Young;
    • Pal, Sumanta;
    • Koralewski, Piotr;
    • Stroyakovskiy, Daniil;
    • Alekseev, Boris;
    • Parnis, Francis;
    • Castellano, Daniel;
    • Lee, Jae Lyun;
    • Sunela, Kaisa;
    • Ciuleanu, Tudor;
    • Heng, Daniel;
    • Glen, Hilary;
    • Wang, Jinyi;
    • Bennett, Lee;
    • Pan, Janice;
    • O'Hara, Karen;
    • Puente, Javier
    Publication type:
    Article
    10
    11

    The Survival and Financial Benefit of Investigator-Initiated Trials Conducted by Korean Cancer Study Group.

    Published in:
    Cancer Research & Treatment, 2025, v. 57, n. 1, p. 39, doi. 10.4143/crt.2024.421
    By:
    • Kim, Bum Jun;
    • Maeng, Chi Hoon;
    • Keam, Bhumsuk;
    • Im, Young-Hyuck;
    • Ro, Jungsil;
    • Jung, Kyung Hae;
    • Im, Seock-Ah;
    • Kim, Tae Won;
    • Lee, Jae Lyun;
    • Heo, Dae Seog;
    • Kim, Sang-We;
    • Park, Keunchil;
    • Ahn, Myung-Ju;
    • Cho, Byoung Chul;
    • Kim, Hoon-Kyo;
    • Kang, Yoon-Koo;
    • Cho, Jae Yong;
    • Yun, Hwan Jung;
    • Nam, Byung-Ho;
    • Zang, Dae Young
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma.

    Published in:
    JAMA Network Open, 2022, v. 5, n. 6, p. e2216379, doi. 10.1001/jamanetworkopen.2022.16379
    By:
    • Navani, Vishal;
    • Ernst, Matthew;
    • Wells, J. Connor;
    • Yuasa, Takeshi;
    • Takemura, Kosuke;
    • Donskov, Frede;
    • Basappa, Naveen S.;
    • Schmidt, Andrew;
    • Pal, Sumanta K.;
    • Meza, Luis;
    • Wood, Lori A.;
    • Ernst, D. Scott;
    • Szabados, Bernadett;
    • Powles, Thomas;
    • McKay, Rana R.;
    • Weickhardt, Andrew;
    • Suarez, Cristina;
    • Kapoor, Anil;
    • Lee, Jae Lyun;
    • Choueiri, Toni K.
    Publication type:
    Article
    27

    Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 4, p. 1212, doi. 10.1002/cam4.3717
    By:
    • Gan, Chun Loo;
    • Dudani, Shaan;
    • Wells, J. Connor;
    • Donskov, Frede;
    • Pal, Sumanta K.;
    • Dizman, Nazli;
    • Rathi, Nityam;
    • Beuselinck, Benoit;
    • Yan, Flora;
    • Lalani, Aly‐Khan A.;
    • Hansen, Aaron;
    • Szabados, Bernadett;
    • Velasco, Guillermo;
    • Tran, Ben;
    • Lee, Jae Lyun;
    • Vaishampayan, Ulka N.;
    • Bjarnason, Georg A.;
    • Subasri, Mathushan;
    • Choueiri, Toni K.;
    • Heng, Daniel Y. C.
    Publication type:
    Article
    28

    Characterizing the outcomes of metastatic papillary renal cell carcinoma.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 5, p. 902, doi. 10.1002/cam4.1048
    By:
    • Connor Wells, John;
    • Donskov, Frede;
    • Fraccon, Anna P.;
    • Pasini, Felice;
    • Bjarnason, Georg A.;
    • Beuselinck, Benoit;
    • Knox, Jennifer J.;
    • Rha, Sun Young;
    • Agarwal, Neeraj;
    • Bowman, Isaac Alex;
    • Lee, Jae‐Lyun;
    • Pal, Sumanta K.;
    • Srinivas, Sandy;
    • Scott Ernst, Douglas;
    • Vaishampayan, Ulka N.;
    • Wood, Lori A.;
    • Simpson, Robin;
    • De Velasco, Guillermo;
    • Choueiri, Toni K.;
    • Heng, Daniel Y. C.
    Publication type:
    Article
    29

    Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

    Published in:
    Medical Oncology, 2012, v. 29, n. 5, p. 3291, doi. 10.1007/s12032-012-0227-7
    By:
    • Park, Kwonoh;
    • Lee, Jae-Lyun;
    • Park, Inkeun;
    • Park, Seongjoon;
    • Ahn, Yongcheol;
    • Ahn, Jin-Hee;
    • Ahn, Shin;
    • Song, Cheryn;
    • Hong, Jun;
    • Kim, Choung-Soo;
    • Ahn, Hanjong
    Publication type:
    Article
    30

    Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-29441-y
    By:
    • van der Heijden, Michiel S.;
    • Powles, Thomas;
    • Petrylak, Daniel;
    • de Wit, Ronald;
    • Necchi, Andrea;
    • Sternberg, Cora N.;
    • Matsubara, Nobuaki;
    • Nishiyama, Hiroyuki;
    • Castellano, Daniel;
    • Hussain, Syed A.;
    • Bamias, Aristotelis;
    • Gakis, Georgios;
    • Lee, Jae-Lyun;
    • Tagawa, Scott T.;
    • Vaishampayan, Ulka;
    • Aragon-Ching, Jeanny B.;
    • Eigl, Bernie J.;
    • Hozak, Rebecca R.;
    • Rasmussen, Erik R.;
    • Xia, Meng Summer
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50